AlzChem Group AG

  • WKN: A2YNT3
  • ISIN: DE000A2YNT30
  • Land: Deutschland

Nachricht vom 14.11.2019 | 06:30

AlzChem Group AG posts sales and earnings for the first nine months of 2019 at previous year's level

DGAP-News: AlzChem Group AG / Key word(s): Quarterly / Interim Statement/9 Month figures
14.11.2019 / 06:30
The issuer is solely responsible for the content of this announcement.

AlzChem Group AG posts sales and earnings for the first nine months of 2019 at previous year's level


Trostberg, November 14, 2019 - AlzChem Group AG, a vertically integrated specialty chemicals supplier with a leading market position in selected niche markets, was able to confirm the previous year's level in both sales and earnings in the first nine months of 2019. Group sales in the reporting period amounted to EUR 287.7 million (9M 2018: EUR 287.2 million). The third quarter made a significant contribution with a sales increase of 8.1% to EUR 99.4 million. Over the nine-month period, a slight decline in sales in the Specialty Chemicals segment (-4.9%) was offset by a significant increase in sales in the Basics & Intermediates segment (+7.5%). The highlight of the third quarter of 2019 was the official commissioning of the new Creamino(R) plant at the Trostberg site in mid-September. Production capacity, which has tripled to around 21,000 tons, is now gradually being utilized in line with expected market growth.

On the earnings side, AlzChem successfully passed on significant cost increases (including for raw materials and personnel) through price adjustments (+3.0%). In addition, the product portfolio was further developed towards more complex and thus more high-priced products. Overall, AlzChem achieved earnings before interest, taxes, depreciation and amortization (EBITDA) of EUR 41.4 million (9M 2018: EUR 41.3 million), equivalent to an EBITDA margin of 14.4% (9M 2018: 14.4%). Consolidated net income for the period amounted to EUR 17.0 million, compared with EUR 20.4 million in the previous year. This was due to high extraordinary additions to pension provisions due to sharply falling interest rates.

For 2019 as a whole, AlzChem is forecasting consolidated sales of between EUR 375.0 million and EUR 385.0 million (2018: EUR 375.2 million) and adjusted EBITDA of between EUR 46.5 million and EUR 51.9 million (2018: EUR 49.4 million).

The detailed quarterly statement is available for download on the website www.alzchem.com under Investor Relations/Publications/Financial Reports.

About AlzChem
The AlzChem Group is a vertically integrated manufacturer of chemical products based on the so-called NCN chain. These are products with typical nitrogen-carbon-nitrogen bonding that are used in a wide variety of different industries. The Group has a leading position in select niche markets. The strategic focus of growth and the main focus of its extensive research and development are on the business segment Specialty Chemicals. The company has around 1,560 employees at four sites in Germany and three other sites abroad.



14.11.2019 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de



show this

Interview im Fokus

Mountain Alliance: „Großer Digitalisierungsschub“

Furioses Börsendebüt für den Datenbankspezialisten Exasol. Einer der Profiteure: Die Münchner Beteiligungsgesellschaft Mountain Alliance AG (MA, ISIN DE000A12UK08), die auch nach einem Teilexit noch rund 2% an Exasol hält. Aktuell notiert die MA-Aktie rund 30 % unter dem NAV. Financial.de sprach mit MA-CEO Daniel Wild über die stärksten Digitalisierungstrends, die kritische Größe von 100 Mio. Euro Börsenwert, den neuen Investor und weitere Aktienkäufe.

GBC-Fokusbox

Aves One AG: Kursziel 13,60 €

Die Aves One AG ist auch in der Corona-Krise als Bestandshalter von langlebigen Logistik-Assets mit langfristigen Mietverträgen gut aufgestellt. Das Unternehmen hat als Guidance einen Umsatz und ein EBITDA mindestens auf Vorjahresniveau verkündet. Unseres Erachtens sollte dies auch ohne Zukäufe gut machbar sein, da die im abgelaufenen Geschäftsjahr 2019 erworbenen Assets bereits zu einer höheren Umsatzbasis führen sollten. Auf Basis unseres DCF-Modells haben wir ein Kursziel in Höhe von 13,60 € ermittelt und vergeben ein KAUFEN-Rating.

Aktuelle Research-Studie

DEAG Deutsche Entertainment Aktiengesellschaft

Original-Research: DEAG Deutsche Entertainment AG (von Montega AG): Kaufen

02. Juni 2020